iQ Biosciences

iQ Biosciences is a specialized immunology-focused CRO founded in 2018 and based in Berkeley, California. It provides critical preclinical research services and high-quality biological reagents to drug developers, primarily in the biotech and pharmaceutical sectors. The company differentiates itself through a customer-centric, end-to-end project management approach, deep scientific expertise, and a commitment to rigorous, timely data delivery. Its services are designed to de-risk early-stage therapeutic development, particularly for antibody, cell therapy, and antibody-drug conjugate programs.

Integrated service platform combining in-vitro assay design/execution, bioconjugation expertise, and supply of quality immune cell biospecimens, supported by deep immunology knowledge.

Competes in the fragmented preclinical CRO market against large players (e.g., LabCorp, Charles River) offering broad services and smaller niche immunology CROs. Differentiation is based on deep immunology expertise, a consultative partnership model, and a focus on quality reagents and rigorous, timely data delivery for complex therapeutic modalities.